Compare TLSI & ASUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSI | ASUR |
|---|---|---|
| Founded | 2010 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.2M | 261.9M |
| IPO Year | 2020 | 1996 |
| Metric | TLSI | ASUR |
|---|---|---|
| Price | $5.08 | $9.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $14.33 |
| AVG Volume (30 Days) | ★ 153.0K | 96.4K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $45,151,000.00 | ★ $88,952,000.00 |
| Revenue This Year | $35.45 | $16.33 |
| Revenue Next Year | $37.58 | $9.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 53.41 | ★ 63.39 |
| 52 Week Low | $2.20 | $6.80 |
| 52 Week High | $7.95 | $10.20 |
| Indicator | TLSI | ASUR |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 64.23 |
| Support Level | $4.21 | $8.81 |
| Resistance Level | $5.58 | $9.75 |
| Average True Range (ATR) | 0.30 | 0.33 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 28.73 | 88.94 |
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.